who makes ozempic semaglutide is first GLP-1 drug FDA-approved for kidney disease SkinnyRx | Ozempic

23 May SAHPRA and the SAPC Crack Down on Unlawful Manufacturing of Unregistered GLP-1/ GIP Medicines Pretoria, 23 May 2026 The South African Health Products Regulatory Authority (SAHPRA), in collaboration with the South African Pharmacy Council (SAPC), has intensified enforcement action against the unlawful manufacturing and distribution of unregistered GLP-1 and GIP medicines containing either Semaglutide, Tirzepatide, or a combination product containing both Semaglutide and Tirzepatide promoted for weight loss

This once-weekly injection demonstrated an average 20.9% body weight reduction in clinical trials

For broader context on how semaglutide compares to other options, our peptides for weight loss overview and the detailed best peptides for weight loss ranking provide comprehensive comparisons

The AAP and the U.S

This is an inflammatory form of scarring hair loss your immune system attacks your hair follicles and lay down scar tissue that often comes on gradually